evolcSign inStart free
Menu

Eco Animal Health

Veterinary medicines and vaccines for pig, poultry and cattle producers, sold directly and through distributors in over 70 countries

London, United KingdomFounded 1991ecoanimalhealth.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-02

About Eco Animal Health

ECO Animal Health develops, registers and markets branded veterinary products for livestock. Its focus is on economically important respiratory and enteric diseases. Its lead product, Aivlosin, is a patented medication for respiratory and intestinal diseases in pigs and poultry, sold under the name Valosin in some markets. The Ecomectin range covers internal and external parasites in cattle, sheep and pigs. ECOVAXXIN MS, a poultry vaccine against Mycoplasma synoviae, is the first product from its pipeline to launch commercially in the European Union.

Customers are livestock producers and veterinary markets. The company sells through a network of distributors and partners in over 70 countries and also supplies private-label parasiticide brands for other customers. The pipeline includes a long-acting florfenicol antibiotic for pigs in late-stage development and vaccine projects with research institutions and for porcine reproductive and respiratory syndrome virus (PRRSV).

The company was founded in 1991 and is headquartered in London, United Kingdom. It is listed on the AIM market of the London Stock Exchange. It is a member of the National Office of Animal Health (NOAH) and supports the Responsible Use of Medicines in Agriculture Alliance (RUMA).

Product: Aivlosin (Valosin) antibiotic for pigs and poultry, Ecomectin parasiticides for cattle, sheep and pigs, and ECOVAXXIN MS poultry vaccine.

Jobs at Eco Animal Health

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Elasmogen

    Biopharma developing ELN28, a dual-acting TNFα and JAK inhibitor conjugate for hidradenitis suppurativa patients
    Foresterhill, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

  • Eleventx

    Extended-release RNA medicines for chronic disease, starting in cardiometabolic, developed with pharma partners
    Cambridge, United KingdomBiotech & pharma2 open jobs

  • Enara Bio

    Cancer immunotherapies for patients with solid tumors, developed using dark-antigen discovery and T-cell engager platforms
    Oxford, United KingdomBiotech & pharmaFounded 2016
    New on Evolc

  • Engivent

    Programmable microfluidic and automation systems for biology and biotechnology research teams
    Cambridge, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

  • Ensocell

    AI-driven discovery of precision therapies for fibrotic and autoimmune diseases using human biological data
    Cambridge, United KingdomBiotech & pharmaFounded 20231 open job
    Young company

  • Enterobiotix

    Clinical-stage microbiome therapeutics developing the oral drug EBX-102-02 for irritable bowel syndrome and related gut and liver diseases
    Bellshill, United KingdomBiotech & pharmaFounded 2017

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Contact Form 7High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.